Zepp Health CORP (ZEPP) — SEC Filings

Q: What are the key financial highlights for Zepp Health CORP?

Key financial highlights for Zepp Health CORP are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Zepp Health CORP?

Key executives at Zepp Health CORP are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Zepp Health CORP stock?

Risk factors for Zepp Health CORP (ZEPP) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Zepp Health CORP?

Forward-looking statements and predictions from Zepp Health CORP are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Zepp Health CORP. Recent 20-F filing on Apr 24, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Zepp Health CORP on SEC EDGAR

Overview

Zepp Health CORP (ZEPP) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 20-F filed on Apr 24, 2026: Zepp Health Corp. filed its annual report on Form 20-F on April 24, 2026, for the fiscal year ending December 31, 2025. The filing includes various exhibits such as financial statements and other disclosures. The company's mailing and business addresses are located in Hefei, China.

Sentiment Summary

Across 22 filings, the sentiment breakdown is: 22 neutral. The dominant filing sentiment for Zepp Health CORP is neutral.

Filing Type Overview

Zepp Health CORP (ZEPP) has filed 3 20-F, 11 6-K, 2 20-F/A, 6 SC 13G/A with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (22)

Zepp Health Files 2025 Annual Report — 20-F · Apr 24, 2026 Risk: medium
Zepp Health Corp. filed its annual report on Form 20-F on April 24, 2026, for the fiscal year ending December 31, 2025. The filing includes various exhibits suc
6-K Filing — 6-K · Nov 5, 2025
Zepp Health Corp. Files August 2025 6-K Report — 6-K · Aug 4, 2025 Risk: low
Zepp Health Corp. filed a Form 6-K on August 4, 2025, to report its activities for the month of August 2025. The filing includes a press release as Exhibit 99.1
Zepp Health Corp Files 2024 Annual Report Amendment — 20-F/A · May 21, 2025 Risk: medium
Zepp Health Corp filed an amendment (20-F/A) on May 21, 2025, for its fiscal year ending December 31, 2024. The company, formerly known as Huami Corp, is incorp
Zepp Health Files 6-K Report — 6-K · May 20, 2025 Risk: low
Zepp Health Corporation filed a Form 6-K on May 20, 2025, to report information as a foreign private issuer. The filing includes Exhibit 99.1, which is a press
Zepp Health Files 2024 Annual Report — 20-F · Apr 25, 2025 Risk: medium
Zepp Health Corp. filed its 20-F annual report for the fiscal year ending December 31, 2024. The company, formerly known as Huami Corp. until October 23, 2017,
Zepp Health Corp Files March 2025 6-K Report — 6-K · Mar 27, 2025 Risk: low
Zepp Health Corporation (formerly Huami Corp) filed a Form 6-K on March 27, 2025, to report its activities for the month of March 2025. The filing includes a pr
Zepp Health Corp Files November 2024 6-K Report — 6-K · Nov 19, 2024 Risk: low
Zepp Health Corporation, formerly Huami Corp, filed a Form 6-K on November 19, 2024. This report is for the month of November 2024 and indicates the company is
SC 13G/A Filing — SC 13G/A · Nov 12, 2024
Zepp Health Corp Files October 2024 6-K Report — 6-K · Oct 4, 2024 Risk: low
Zepp Health Corporation (formerly Huami Corp) filed a Form 6-K on October 4, 2024. This report is for the month of October 2024 and indicates the company is a f
SC 13G/A Filing — SC 13G/A · Oct 4, 2024
Zepp Health Corp Files 6-K Report — 6-K · Sep 6, 2024 Risk: low
Zepp Health Corporation (formerly Huami Corp) filed a Form 6-K on September 6, 2024. This report is for the month of September 2024 and indicates the company is
Zepp Health Corp Files 6-K Report — 6-K · Sep 4, 2024 Risk: low
Zepp Health Corporation (formerly Huami Corp) filed a Form 6-K on September 4, 2024. This report includes a press release as Exhibit 99.1. The company is incorp
Zepp Health Files 6-K Report — 6-K · Aug 22, 2024 Risk: low
Zepp Health Corporation (formerly Huami Corp) filed a Form 6-K on August 22, 2024, reporting for the month of August 2024. The filing includes a press release a
Zepp Health Files 2023 Annual Report Amendment — 20-F/A · Jun 27, 2024 Risk: medium
Zepp Health Corp filed an amendment (20-F/A) to its annual report for the fiscal year ended December 31, 2023. The filing, submitted on June 27, 2024, provides
Zepp Health Corp Files May 2024 6-K Report — 6-K · May 22, 2024 Risk: low
Zepp Health Corporation, formerly Huami Corp, filed a Form 6-K on May 22, 2024. This report is a filing for the month of May 2024 and includes a press release a
Zepp Health Corp. Files Annual Report on Form 20-F — 20-F · Apr 23, 2024 Risk: medium
Zepp Health Corp (ZEPP) filed a Foreign Annual Report (20-F) with the SEC on April 23, 2024. Zepp Health Corp. filed its annual report on Form 20-F for the fisc
Zepp Health Corp Files 6-K Report — 6-K · Mar 19, 2024 Risk: low
Zepp Health Corporation (formerly Huami Corp) filed a Form 6-K on March 19, 2024, to report information as a foreign private issuer. The filing includes a press
FIL Limited Reports 9.069% Stake in Zepp Health Corp. — SC 13G/A · Feb 9, 2024 Risk: low
FIL Limited, a Bermuda-based investment manager, has updated its ownership stake in Zepp Health Corp. (formerly Huami Corp.) Class A Common Stock. As of Decembe
Goldman Sachs AM Updates Zepp Health Stake in SC 13G/A Filing — SC 13G/A · Feb 8, 2024 Risk: low
Goldman Sachs Asset Management, L.P. filed an amended SC 13G/A on February 8, 2024, indicating their ownership in Zepp Health Corp. (formerly Huami Corp.) as of
Zepp Health CEO Huang Wang Updates Beneficial Ownership in SC 13G/A — SC 13G/A · Jan 19, 2024
Huang Wang, the CEO of Zepp Health Corp, has filed an Amendment No. 6 to his SC 13G, indicating a change in his beneficial ownership of Zepp Health's Class A or
Allspring Global Investments Updates Zepp Health Stake — SC 13G/A · Jan 12, 2024
Allspring Global Investments Holdings, LLC filed an amended SC 13G/A on January 12, 2024, indicating their ownership in Zepp Health Corp's Sponsored ADS as of D

Risk Profile

Risk Assessment: Of ZEPP's 17 recent filings, 0 were flagged as high-risk, 5 as medium-risk, and 12 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

Leon Deng

Top Tags

amendment (6) · sec-filing (5) · annual-report (4) · foreign-private-issuer (4) · 6-k (3) · disclosure (3) · regulatory-filing (3) · 6-K (3) · institutional-ownership (3) · financials (2)

Key Numbers

20-F Document Size: 4246695 — Indicates the size of the main 20-F filing in bytes.
Complete Submission Text File Size: 17322964 — Represents the total size of the submission in bytes.
Reporting Period: August 2025 — The 6-K report covers activities during this month.
Fiscal Year End: 2024 — The period covered by the annual report.
Filing Date: 20250521 — The date the amendment was submitted to the SEC.
Accrued Liabilities and Other Liabilities: 1246000 — This figure represents a specific liability amount reported for the fiscal year.
Central Index Key: 0001720446 — Company identifier
SEC File Number: 001-38369 — SEC filing identifier
shares beneficially owned: 11,512,720 — total shares held by FIL Limited and affiliates in Zepp Health Corp.
percentage of class: 9.069% — the ownership percentage of Zepp Health Corp. Class A Common Stock held by FIL Limited and affiliates
sole voting power shares: 9,898,964 — shares over which FIL Limited has sole voting power
CUSIP Number: 44331K103 — identifies Zepp Health Corp's American depositary shares
Amendment Number: 5 — indicates this is the fifth amendment to the original SC 13G filing

Forward-Looking Statements

{"claim":"FIL Limited will maintain a significant stake in Zepp Health Corp. for the foreseeable future.","entity":"FIL Limited","targetDate":"2025-02-09","confidence":"high"}
{"claim":"Goldman Sachs Asset Management will likely maintain its institutional ownership in Zepp Health Corp for the foreseeable future.","entity":"Goldman Sachs Asset Management, L.P.","targetDate":"Next 12 months","confidence":"medium"}

Frequently Asked Questions

What are the latest SEC filings for Zepp Health CORP (ZEPP)?

Zepp Health CORP has 22 recent SEC filings from Jan 2024 to Apr 2026, including 11 6-K, 6 SC 13G/A, 3 20-F. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of ZEPP filings?

Across 22 filings, the sentiment breakdown is: 22 neutral. The dominant sentiment is neutral.

Where can I find Zepp Health CORP SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Zepp Health CORP (ZEPP) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Zepp Health CORP?

Financial highlights for Zepp Health CORP are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.

What is the investment thesis for ZEPP?

The investment thesis for ZEPP includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Zepp Health CORP?

Key executives identified across Zepp Health CORP's filings include Leon Deng.

What are the main risk factors for Zepp Health CORP stock?

Of ZEPP's 17 assessed filings, 0 were flagged high-risk, 5 medium-risk, and 12 low-risk.

What are recent predictions and forward guidance from Zepp Health CORP?

Recent forward-looking statements from Zepp Health CORP include guidance on {"claim":"FIL Limited will maintain a significant stake in Zepp Health Corp. for the foreseeable future.","entity":"FIL and 1 other predictions.